Insider Trading History of Dellio Clarence L

The following table details the insider trading activities (stock purchases, stock sales, and stock option exercises) by Dellio Clarence L since 2005. The trader's CIK number is 1221680. At the time of the last reporting, Dellio Clarence L was the Sr VP, Operations an of Aevi Genomic Medicine, Llc. (stock ticker symbol CERC). Also see all insider trading activities at Aevi Genomic Medicine, Llc.

Note that in the past DELLIO CLARENCE L also reported insider trading activities as an insider of the following companies:

Yearly summary of insider trading at Xoma Corp (XOMA) by Dellio Clarence L

Insider Buying Insider Sales Option Exercises
Year Symbol Shares Value Shares Value Shares Value
2005 XOMA 0 $0 10,974 $15,473 0 $0

Yearly summary of insider trading at Aevi Genomic Medicine, Llc (MDGN) by Dellio Clarence L

Insider Buying Insider Sales Option Exercises
Year Symbol Shares Value Shares Value Shares Value
2013 MDGN 1,000 $4,139 2,000 $13,000 3,500 $12,740
2012 MDGN 0 $0 3,007 $32,295 4,300 $15,652


Insider trading activities at 2 companies by Dellio Clarence L:

1. Xoma Corp (XOMA)

2. Aevi Genomic Medicine, Llc (MDGN)

Table 1. Insider trading of Xoma Corp (XOMA) by Dellio Clarence L

Trade Date Symbol Trade Type Shares Price ($) Value ($)
2005-05-11 XOMA Sale 10,974 1.41 15,473

Table 2. Insider trading of Aevi Genomic Medicine, Llc (MDGN) by Dellio Clarence L

Trade Date Symbol Trade Type Shares Price ($) Value ($)
2013-12-06 MDGN Sale 2,000 6.50 13,000
2013-06-04 MDGN Buy 712 4.14 2,947
2013-06-03 MDGN Buy 288 4.14 1,192
2013-03-20 MDGN Option Ex 3,500 3.64 12,740
2012-09-14 MDGN Sale 3,007 10.74 32,295
2012-09-11 MDGN Option Ex 4,300 3.64 15,652

Insider trading activities including stock purchases, stock sales, and option exercises listed in the above table cannot be completely guaranteed as to their accuracy. For more information regarding the trades made by Dellio Clarence L (Sr VP, Operations an of Aevi Genomic Medicine, Llc at the time of this reporting) see the Securities and Exchange Commission (SEC) website.



©2023, insider-monitor.com. All rights reserved.